Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant degarelix versus triptorelin with letrozole in premenopausal endocrine-responsive breast cancer
2012-005326-29Phase 2Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Letrozole + degarelix with Letrozole + triptorelin (2 arms). Primary endpoint: Time to optimal ovarian function suppression. Started Sep 2013; status: completed.
02
Drugs
degarelixtriptorelinletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-005326-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005326-29.